CBD Marketing as Medical Treatment Warned by FDA
FDA issued warning letters on November 21 that may signal a shift in enforcement posture away from solely targeting companies that market CBD as a potential medical treatment and towards including companies that market their products in ways that could cause consumer confusion.
Source: natlawreview.com